Date de publication: 30 mai 2024
Promoteur – Intermédiaire Financier
MEDACCESS GUARANTEE LTDLieu
Description
The project will support health systems by enabling MedAccess to provide volume and procurement guarantees for essential medical supplies. The pipeline includes the purchase of vaccines as well as eligible investments in innovation and manufacturing scale-up.
Objectifs
The aim is to increase the access and availability of medicinal products, including vaccines, for the benefit of low- and middle-income countries thus reducing the burden of endemic diseases and malnutrition.
Secteur(s)
- Santé - Santé humaine et action sociale
Under Global Europe NDICI guarantee
Under EFSD+ Guarantee
Montant BEI envisagé (montant approximatif)
EUR 57 million
Coût total (montant approximatif)
EUR 200 million
Aspects environnementaux
The implementation of the project will be done in line with the principles of EU environmental legislation and EIB Environmental and Social Standards.
Passation des marchés
The Bank will require that implementation of the project needs to be done in accordance with the EIB's Guide to Procurement.
Statut
Approuvé - 15/05/2025